Physicians’ knowledge, beliefs, and use of race and human genetic variation: new measures and insights by unknown
Bonham et al. BMC Health Services Research 2014, 14:456
http://www.biomedcentral.com/1472-6963/14/456RESEARCH ARTICLE Open AccessPhysicians’ knowledge, beliefs, and use of race
and human genetic variation: new measures and
insights
Vence L Bonham1*†, Sherrill L Sellers2*† and Sam Woolford3Abstract
Background: Understanding physician perspectives on the intersection of race and genomics in clinical decision
making is critical as personalized medicine and genomics become more integrated in health care services. There is
a paucity of literature in the United States of America (USA) and globally regarding how health care providers
understand and use information about race, ethnicity and genetic variation in their clinical decision making. This
paper describes the development of three scales related to addressing this gap in the literature: the Bonham and
Sellers Genetic Variation Knowledge Assessment Index–GKAI, Health Professionals Beliefs about Race—HPBR, and
Racial Attributes in Clinical Evaluation—RACE scales.
Methods: A cross-sectional, web survey of a national random sample of general internists in the USA (N = 787) was
conducted. Confirmatory factor analysis was used to assess the construct validity of the scales. Scale items were
developed through focus groups, cognitive interviews, expert advisory panels, and exploratory factor analysis of
pilot data.
Results: GKAI was measured as a count of correct answers (Mean = 3.28 SD = 1.17). HPBR yielded two domains:
beliefs about race as a biological phenomenon (HPBR-BD, alpha = .69, 4 items) and beliefs about the clinical value
of race and genetic variation for understanding risk for disease (HPBR-CD alpha = .61, 3 items). RACE yielded one
factor (alpha = .86, 7 items).
Conclusions: GKAI is a timely knowledge scale that can be used to assess health professional knowledge of race
and human genetic variation. HPBR is a promising new tool for assessing health professionals’ beliefs about the role
of race and its relationship with human genetic variation in clinical practice. RACE offers a valid and reliable tool for
assessing explicit use of racial attributes in clinical decision making.
Keywords: Scale development, Medical decision making, Personalized medicine, RACE (Racial Attributes in Clinical
Evaluation), GKAI (Genetic Variation Knowledge Assessment Index), Explicit use of raceBackground
It is well documented that the use of race and ethnicity
as surrogate markers for describing one’s risk for disease
on a genomic level is common in both clinical practice
[1] and research settings [2-7]. The utility of race to pre-
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unless otherwise stated.of treatment in clinical practice within the USA has been
described by Barr as the “practitioner’s dilemma: can health
care providers use a patient’s race to predict genetic
variation, ancestry and outcomes in treatment?” [8]. We
provide researchers with new survey measures to study
physicians’ explicit use of patient’s race in clinical care,
particularly to study health care providers’ knowledge of
genetic variation, beliefs about race and genetic differences
and explicit use of race in clinical decision making.
New scientific knowledge of human genetic variation
is facilitating an understanding of why susceptibility to
common diseases varies among individuals and populationsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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refute the notion that ‘races’ and ‘ethnicities’ are genet-
ically distinct human populations as no sharp genetic
boundaries can be drawn between human population
groups [10]. Self-identified race and ethnicity correlate
with “genetic population groups” but do not necessarily
correlate with an individual’s distinct genetic background
[11,12]. Thus, there is some confusion and debate as to
the relationships between risk of diseases and self-
identified race [13-15].
Some researchers argue that racial and ethnic categories
can serve as useful variables to investigate the genetic
component of disease and patients' responses to treat-
ment, while others contest the utility of race for under-
standing genetic variation [14,16]. Many social scientists
and health services researchers believe that the study of
race is necessary to understand the social determinants
of health [17,18]. However, many are concerned that if
physicians rely on race as a proxy for genetic risk, this
could exacerbate racial and ethnic healthcare disparities
in the USA and may even lead to poorer quality of care
for all patients [13,19,20].
Some studies suggest that physicians consciously and
subconsciously incorporate racial information about
patients into their communication styles and decision
making [21-23], but limited research has examined
clinicians’ attitudes towards the relationship between
race and genetic variation in clinical decision making
[24]. Understanding how primary care physicians think
about the intersection of race and genetics is critical
for health disparities and health services research given
the current racial and ethnic inequities in healthcare,
the advancements of genomic medicine, and its early
translation to health care.
This gap in the literature is, in part, due to a lack of
reliable and valid measures to assess the role of race and
genetics in clinical decision making processes. In order
to assess these complex relationships, new measures,
with good psychometric properties, are needed. To this
end, we developed the Genetic Variation Knowledge
Assessment Index (GKAI) to assess physicians’ scientific
knowledge of genetic variation, the Health Professionals
Beliefs about Race (HPBR) scale to measure health pro-
fessionals’ beliefs about genetic difference, and the Racial
Attributes in Clinical Evaluation (RACE) scale to investi-
gate health professionals’ use of race in clinical practice.a
In this paper, we describe the process used to develop
these scales; specifically, we present a brief description of
the Physicians Understanding of Human Genetic Vari-
ation (PUHGV) Study, summarize the conceptual model
used to guide the process, and briefly outline the activities
that generated the items used in the final scales. Finally,
we describe in detail the final confirmatory phase under-
taken to characterize each new measure.Conceptual model
To guide the scale development process, we developed a
conceptual model aimed at exploring the use of raceb and
genetic variation in clinical decision making (Figure 1).
Our model derives from an extensive literature review and
interviews with health care providers, representing an in-
tegration of critical race theory, social cognition theory,
and the empirical literatures on clinical decision making,
provider behavior, and the role of genetics and genomics
in complex disease risk [1,22,25-35].
The model consists of six domains: characteristics of
provider and patient; provider knowledge and beliefs;
patient knowledge and beliefsc; the clinical encounter;
interpretation; and the clinical decision. These domains
foreground a seventh domain which we describe as the
racial lens.
The model suggests that this racial lens is a social
frame that influences the cognitive processes within all
aspects of the clinical decision making process in the USA
context, from the clinical encounter through synthesis of
data to the final diagnostic and treatment decisions. The
social frame of the racial lens permeates the clinical deci-
sion making process, is integrated both explicitly and
implicitly by provider and patient, and furthers several hy-
potheses related to the role of race in clinical decision
making. For example, it is possible that race is most influ-
ential in the interpretation and clinical decision phases, es-
pecially when genetic and molecular data are unavailable.
Perhaps health professionals with greater knowledge of
the science of genetic ancestry and genetic variation and
its importance in diagnosis and treatment will use mo-
lecular and genomic information differently than health
professionals who do not have that body of scientific
knowledge [36]. Our model also suggests that genetic and
molecular data could play an important role in challenging
the racial lens and possibly taking the clinical encounter
and thereby other domains of the clinical decision making
process in directions that a racialized clinical encounter
may not. It is possible that health professional’s knowledge
and beliefs about race and human genetic variation could
improve or could encumber their interpretation and
clinical decision. We found, for example, a positive as-
sociation between physicians’ anxiety due to uncertainty
and self-reported use of race in their clinical decision
making [37].
Thus, it is particularly important to study how physicians
and other health professionals interpret and utilize race in
their clinical decision making. We developed scales to
measure the domains of physician knowledge and beliefs
about race and human genetic variation and physician’s use
of race in the domains of interpretation and clinical deci-
sion (see conceptual model). These measures were devel-
oped as part of the Physicians Understanding of Human
Genetic Variation (PUHGV) Study.
Figure 1 Racial Lens In Clinical Decision Making. The conceptual model explores the use of race and genetic variation in clinical decision
making. The model consists of six domains foregrounded by a seventh domain which we describe as the racial lens. Our model suggests that
this racial lens influences all aspects of the clinical decision making process.
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oped within a three phased project designed to under-
stand physicians’ knowledge of human genetic variation
and the role of race in the clinical decision making
process. In the first phase, focus groups with 90 general
internists in the USA who self-identified as either black
or white were conducted in order to gain insight into
providers’ opinions on the use of race in clinical decision
making and their views on the relationship between race,
genetics, and disease [20,38,39]. Findings from these
focus groups were used to develop items for the scales.
We conducted 30 semi-structured cognitive interviews
with general internists to assist in the development and
revision of these items. Items were further refined based
on guidance from two panels of experts (geneticists and
survey methodologists).
In Phase II, a pilot instrument, including the three
scales, was tested with a national random sample of 364
general internists. Exploratory factor analysis (EFA) was
used to help diagnose areas of poor fit and to identify
items with low (<.5) loadings. Items with low loadings
were eliminated from the item pool and only those items
with validity and strong theoretical bases were in-
cluded as items in the final scales. The revised scales
were then assessed by three physicians to ensure clarity
and consistency among the core concepts. The currentarticle details the methods and resulting scales from
Phase III of the study.
Methods
Sample
The data were collected between April-December 2010;
the survey was administered via the web and mail to a
national sample of 2122 clinically active general inter-
nists. The sample was drawn from the SK&A company’s
AMA Masterfile physician database in 2 batches. First, a
general random sample (n = 1929) general internists of
all racial and ethnic backgrounds was selected from the
overall database. This was supplemented by a sample of
physicians who graduated from historically black medical
schools (n = 193) in an effort to increase the representation
of black physicians in the overall sample and improve the
study’s ability to detect differences between black physicians
and other physicians. We excluded physicians who were
not currently practicing general internists according to their
office staff or did not have a current (USA) mail address,
and identified a sample size of 1,738 eligible physicians.
Respondents received a $50 incentive for participating.
Potential respondents received six reminders over a six
month period to complete the web survey. After six
contacts, non-responding physicians were sent a paper
version of the survey instrument and their offices were
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the 787 total completed surveys, 108 (13.76%) were
completed and returned using the paper questionnaire.
Analysis indicated no significant differences between
mail and web respondents. The overall response rate
for the survey was 45.35%.
This study was reviewed and approved by the National
Human Genome Research Institute Institutional Review
Board (05-HG-N196). The Principal Investigator requested
and obtained a waiver of requiring a signed consent from
each participant in the study. Participants viewed a state-
ment that described the goals of the study, protection of
personally identifiable information, and a statement that
the survey was voluntary and they could withdraw at any-
time. The participant checked a box that read “I agree to
participate” upon checking the box the participant could
begin the survey.
Survey instrument and scale development
In Phase III, the scale items were included in a nation-
wide, multi-mode (web-based survey with a mail survey
sent to non-responders) survey of practicing general in-
ternists concerning their knowledge and clinical applica-
tion of genetics and genomics. The Health Professionals’
Genetics Education Needs Exploration (HP GENE) Sur-
vey included 81-items that included the items for three
scales and 57 additional items. The final instrument con-
sisted of six sections: (1) scientific knowledge of human
genetic variation; (2) beliefs regarding genetics, race, and
ethnicity; (3) consideration of race in clinical practice;
(4) genetics and genomics in your clinical practice; (5)
clinical decision making approaches; and, (6) demo-
graphic information. The three sections related to the
scales are described below.d
Section 1: Scientific knowledge of human genetic vari-
ation. In this section (Table 1), respondents answeredTable 1 Items for the genetic variation knowledge assessmen
ITEM# QUESTION
GKAI1 The DNA sequences of two randomly selected health
90-95% identical.
GKAI2 Most common diseases, such as diabetes and heart d
GKAI3* Common structural genetic variation (changes in the
duplications and large-scale copy-number variants) is
GKAI4 All the genetic variation in an individual can be attrib
or inherited changes in the human genome.
GKAI5* The variation in the human genome includes both d
that have no effect on health and disease.
GKAI6 Individual genetic variants are usually highly predictiv
GKAI7 Prevalence of many Mendelian diseases differs by rac
GKAI8 Self-reported race is informative of a racial group’s ge
*Item not included in final scoring.
†Correct answer.
**Numbers in parentheses indicate the percentage of respondents who answered ttrue or false to questions such as “the DNA sequences
of two randomly selected healthy individuals of the
same sex are 90-95% identical.” The items in the know-
ledge scale were scored true/false, with a “don’t know”
category. “Don’t know” was considered an incorrect
response for analytic purposes. Scores for knowledge
were obtained by summing the correct responses. Higher
scores indicated a greater knowledge of human genetic
variation.
Section 2: Beliefs regarding genetics, race, and ethni-
city. This section comprised nine items (Table 2) used
to assess physicians’ beliefs regarding the relationship
between race and genetics such as “A patient’s race can
identify patients who can benefit from enhanced screen-
ing for certain diseases.” The items were rated on a 5-
point Likert-type scale (5 = strongly agree to 1 = strongly
disagree).
Section 3: Consideration of race in clinical practice.
This section of the survey included eight items (Table 3)
to assess the degree to which health professionals employ
race in their clinical decision making processes such as “I
consider my patients’ race when making decisions about
which medications to prescribe.” The item response cat-
egories were on a 5-point Likert-type scale (4 = all of the
time to 0 = none of the time).
Analysis
Descriptive statistics were calculated for the items asso-
ciated with all three scales. Confirmatory factor analysis
(CFA) was performed using AMOS 18 to evaluate the
measurement models for the Health Professionals Be-
liefs about Race (HPBR) and Racial Attributes in Clin-
ical Evaluation (RACE) scales, to identify measurement
model changes and to validate each of the resulting
scales. EFA was used to help diagnose areas of poor fit
and to revise the scales for HPBR.t index (GKAI)
†ANSWER
y individuals of the same sex are False (22%)**
isease, are caused by a single gene variant. False (80%)
human genome such as deletions,
important in health and disease.
True (90%)
uted to either spontaneous (i.e., de novo) True (60%)
isease-causing gene variants and variants True (92%)
e of the manifestation of common disease. False (60%)
ial groups. True (69%)
netic ancestral background. True (39%)
he question correctly.
Table 2 Items and standardized factor loadings for the Health Professionals Beliefs about Race (HPBR) scale
ITEM QUESTION LOADING
Biological domain
HPBR-BD1 Genetics usually explains differences in the prevalence of common diseases, such as diabetes and
kidney disease, among racial groups.
.53
HPBR-BD2 National Census categories of race correspond with genetic differences. .53
HPBR-BD3 Race is the best proxy clinicians have to identify genetic effects on health. .68
HPBR-BD4 A clinician’s best predictor of treatment response is the patient’s self-identified race. .67
HPBR-BD5* A patient’s race provides important information about a patient’s risk of disease.
Clinical domain
HPBR-CD1 A patient’s race can identify patients who can benefit from enhanced screening for certain diseases. .61
HPBR-CD2 A patient’s race can identify patients who can benefit from referral to genetic services for certain diseases. .71
HPBR-CD3 Human genetic variation provides clues to unraveling the primary causes of specific racial and ethnic
disparities in health.
.47
HPBR-CD4* There are genetic differences in racial groups that influence health.
*Item not included in final scoring.
Biological Domain (HPBR-BD) and Clinical Domain (HPBR-CD).
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Respondents
The demographic characteristics of the respondents
(N = 787) can be found in Table 4. The sample consisted
of almost twice as many males (65.3%) as females (34.7%)
and 75.4% graduated from a medical school in the USA.
While 88.7% of the respondents indicated that they did
not receive genetics training in their primary specialty
training, 84.7% indicated that their knowledge of genetics
was fair or better. The majority of respondents (59.1%)
practice primarily in an office setting, spend an average of
85% (SD = 19.4%) of their time seeing patients and have an
average of 16.4 (SD = 9.6) years in practice post training.
Table 4 compares the demographics of our survey
respondents with demographic data available from the
AMA Physician Masterfile [40]. On those demographics
that permit comparison, the survey respondents appear
to reflect the profile of physicians in the AMA data
except that there appears to be a higher percentage ofTable 3 Items and standardized factor loadings for the Racial
ITEM# QUESTION
RACE1 I consider information from patients about their rac
RACE2 I consider my patients race to better understand th
RACE3 I consider my patients race when making decisions
RACE4 I consider my patients race in determining genetic
(e.g. kidney disease or diabetes).
RACE5 I consider my patients race in making medication d
RACE6 I consider my patients race when determining age
RACE7 I consider my patients race in determining how agg
RACE8* I consider my patients race in determining genetic
(e.g. cystic fibrosis or sickle cell disease).
*Item not included in final scoring.whites in our sample than indicated in the AMA data.
Noting that 27.4% of the AMA data has an unknown
race, it is likely that some of these physicians are white
which would then better reflect the percentage of whites
in our sample.
Scale analysis
Genetic variation knowledge assessment index (GKAI)
An initial analysis of the responses of the items in the
Genetic Variation Knowledge Assessment Index (GKAI)
indicated that over 90% of the responses for two items
(GKAI3 and GKAI5) were correct. These items were
deleted from the scale as they did not sufficiently differen-
tiate respondents (Table 1). The GKAI was created by
summing the number of correct responses of the
remaining items. The resulting GKAI covers the full
range from zero to six, has a mean of 3.28 (SD = 1.17) and
is roughly symmetric and unimodal. The GKAI has statis-
tically significant correlation with only one item of theAttributes in Clinical Evaluation (RACE) scale
LOADINGS
ial background. .61
eir genetic predispositions. .69
about which medications to prescribe. .74
risk for common, complex diseases .77
osage decisions. .64
of initiation of screening for certain diseases. .66
ressively to treat particular diseases. .61
risk for single gene conditions
Table 4 Characteristics of physician respondents and U.S. internal medicine physicians
Sample characteristics† N % Mean SD AMA* (%)
Total internal medicine physicians 787 -- -- --
Mean age 767 -- 48.6 9.6 --
Gender
Male 505 65.3 -- -- 67.2
Female 269 34.7 -- -- 32.8
Ethnicity
Hispanic/Latino 27 3.5 -- -- 4.9
Race
White 515 67.1 -- -- 44
Black or African-American 49 6.4 -- -- 3.9
Asian 160 20.8 -- -- 17.4
American Indian/Alaska Native 9 1.2 -- -- 0.1
Native Hawaiian/Pacific Islander 2 0.3 -- -- --
Other 54 7 -- -- 2.3
Are you a graduate of US Medical School?
Yes 584 75.4 -- -- --
No 190 24.5 -- -- --
Did you have genetics training in primary specialty residency?
Yes 87 11.3 -- -- --
No 684 88.7 -- -- --
Mean years in practice post-training 769 -- 16.4 9.6 --
Primary practice setting
Academic health center 89 11.4 -- -- --
Federally Qualified Health Center 23 2.9 -- -- --
Group or staff model practice HMO 62 7.9 -- -- --
Hospital based 105 13.5 -- -- --
Office based 459 59.1 -- -- --
VA healthcare system 15 1.9 -- -- --
Other 24 3.1 -- -- --
Affiliation with academic institution?
Yes 304 39.2 -- -- --
No 471 60.8 -- -- --
Percentage of work time seeing patients 772 85 -- -- --
How would you rate your knowledge of genetics?
Excellent 4 0.5 -- -- --
Very good 36 4.6 -- -- --
Good 184 23.7 -- -- --
Fair 433 55.9 -- -- --
Poor 118 15.2 -- -- --
†Questions taken from the Health Professionals’ Genetics Education Needs Exploration (HP GENE) Survey.
*N = 160,107. Data taken from the AMA’s Physician Characteristics and Distribution in the US book, 2010 Edition.
-- Data not available.
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cases, these correlations are small and could be considered
random occurrences.Health professionals beliefs about race (HPBR) scale
A CFA indicated that our initial hypothesis of a single
scale was not supported by the data (Table 2 & Figure 2).
e1















Figure 2 Health Professional Beliefs and Race Scale (HPBR). The
scale consists of two domains representing beliefs about race as a
biological phenomenon (HPBR-BD) and beliefs about the clinical
importance of race (HPBR-CD). Confirmatory Factor Analysis for this
model indicated that a correlation between the errors associated
with items HPBR-BD1 and HPBR-CD3 should be included
(the highest interpretable modification index).
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sisted of two domains representing beliefs about race
as a biological phenomenon (HPBR-BD) and beliefs
about the clinical importance of race (HPBR-CD). The
Cronbach’s alpha for the items included in the bio-
logical domain (HPBR-BD) was .69 and for the clinical
domain (HPBR-CD) was .61, both of which are at the
lower end of the range generally considered acceptable.
A CFA for this model (Figure 2) was fit and the diag-
nostics indicated that a correlation between the errors
associated with items HPBR-BD1 and HPBR-CD3
should be included. The resulting CFA was evaluated
using a variety of measures [41]. The chi-square (43.6 with
12 degrees of freedom and p < .001) was significant but
this could have been a result of the large sample size
(n = 761).e Other measures such as the GFI (.984),
AGFI (.92), CFI (.96) and RMSEA (.059) all indicated
an adequate fit to the data. The item loadings were all
positive and statistically significant (p < .001) and thecorrelation was also positive and statistically significant
(p < .001). The standardized loadings for HPBR-BD
ranged from .53 to .68 resulting in communalities ran-
ging from .28 to .46. The average variance extracted for
HPBR-BD was .36 and the reliability was .69. The stan-
dardized loadings for HPBR-CD ranged from .47 to .71
resulting in communalities ranging from .22 to .50. The
average variance extracted for HPBR-CD was .37 and
the reliability was .64. The correlation between HPBR-
BD and HPBR-CD is .58 and the two constructs satisfy
discriminant validity. Both constructs extract less than
half the variance associated with their measurement
variables. This can be linked to the generally low levels
of correlation (loadings) between the measurement vari-
ables and their constructs. These results suggest that
the convergent validity for the constructs HPBR-BD and
HPBR-CD is not as strong as typically desired. In consid-
eration of the potential similarity between the correlated
items HPBR-BD1 and HPBR-CD3, we refit the model
without HPBR-BD1 and found that the fit characteristics
of the resulting model along with the resulting loadings
were not materially different. Consequently, we opted to
present the current model.
The correlation between the HPBR-BD and HPBR-CD
scales and the GKAI scale is .07 and .07 respectively.
While the correlation between HPBR-BD and GKAI is
just significant at the .05 level (.045) this is consistent
with the large sample size and the possibly random cor-
relations noted above.
Racial attributes in clinical evaluation (RACE) scale
Our initial hypothesis regarding the Racial Attributes in
Clinical Evaluation (RACE) scale included all items indi-
cated in Table 3. A CFA and associated diagnostics indi-
cated that RACE8 should be dropped (Figure 3) and that
correlations between the errors associated with items
RACE1 and RACE2 and between the errors associated
with items RACE5 and RACE7 should be added, which
we did to be consistent with the theoretical intent of the
scale. Incorporating these changes, Cronbach’s alpha for
the remaining items used to measure the RACE scale
is .86. The subsequent CFA model fit was evaluated
using a variety of measures. The chi-square (46.4 with
12 degrees of freedom and p < .001) was significant but
this could have been a result of the large sample size
(n = 761). Other measures such as the GFI (.984), AGFI
(.963), CFI (.984) and RMSEA (.061) all indicated an ad-
equate fit to the data. The final loadings were all positive
and statistically significant (p < .001) and the error correla-
tions (ρ(RACE1, RACE2) = .424, ρ(RACE5, RACE7) = .174)
were also positive and statistically significant (p < .001). The
standardized loadings ranged from .61 to .77 resulting in
communalities ranging from .38 to .59. The average vari-
















Figure 3 Racial Attributes in Clinical Evaluation Scale (RACE).
The scale consists of one domain representing the explicit use of
race. Confirmatory Factor Analysis for this model indicated an
adequate fit to the data. There were no particularly large
modification indices and no additional justifiable parameters
were indicated.
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The correlation of .07 between RACE and GKAI is insig-
nificant (p > .05) while there is a significant correlation of
.51 and .50 with HPBR-BD and HPBR-CD respectively.
Discussion
We developed three measures that assess physicians’
knowledge and beliefs about genetics and genetic vari-
ation and the use of race in clinical decision making.
These scales were the outgrowth of the PUHGV study
qualitative research phase [20,38,39] and a conceptual
model which aimed to facilitate exploration about how
physicians’ understanding of genetic variation and race
might influence the clinical process (Figure 1). We believe
that the measures have the potential to lead to new in-
sights into the intersections of race, genetics, and health.
The Genetic Variation Knowledge Assessment Index
(GKAI) measures health professionals’ knowledge of hu-
man genetic variation, in contrast to health professionals’
perceived knowledge (in analysis not shown, the correl-
ation between GKAI and physicians’ self-reported rating
of their knowledge of genetics was .16). The GKAI was de-
veloped to measure specific domains of factual knowledgeincluding concepts that are deemed important by profes-
sional organizations [42]. The GKAI could be adminis-
tered as a pre-post assessment of health professional
knowledge of race and genetic variation.
In contrast to measuring scientific knowledge, the be-
liefs scales aimed to tap into often implicit assumptions
about race, although these assumptions may be drawn
from experiential knowledge. The belief scales aim to
capture an important, though somewhat understudied
and under theorized area of medical decision making.
Analysis of items to measure beliefs about race suggested
two domains, one related to beliefs about race as a bio-
logical phenomenon (HPBR-BD) and the other related
to beliefs about the clinical value of race and genetic
variation for understanding individual and group-level
risk for disease (HPBR-CD); neither scale exhibited
strong psychometric properties. It is possible that there
are too few items to adequately measure the constructs.
Nonetheless, the HPBR is an important step in develop-
ing a measure that captures health professionals’ beliefs
about the role of race in clinical practice. With further
development, the HPBR may be useful for both designing
interventions and in evaluating them. The scale could be
used in clinical settings to aid health care providers in
more explicitly articulating their beliefs about race. A
clearer articulation of racial beliefs could help health
care professionals better tailor care plans to individual
patients [43] and communicate the complex concept of
genetic variation to the general public. Future research
would also do well to more explicitly link beliefs about
race with knowledge about racial inequality and social
causes of health disparities.
The RACE scale, developed to assess the use of race in
clinical practice, had good psychometric properties. Hav-
ing a valid and reliable measure of physicians’ use of race
has a number of important applications. For example,
the RACE scale could be utilized in cultural competency
curricula to explore the use of race in clinical care. With
the goal of reducing racial and ethnic health disparities
in recent years, there has been an increase in cultural
competency training in the health professions. Although
varied in curricular and content areas, these interventions
target some aspects of knowledge, attitudes/beliefs, and
behaviors of health care professionals [44]. Cultural com-
petency training seeks to impact knowledge, skills and be-
haviors of health care professionals, but few interventions
use objective assessments to measure changes in behavior
[44]. The RACE scale measures self-reported behaviors
and to our knowledge is the first measure of its kind. The
RACE scale intentionally does not provide the respondent
a definition of race. The measure was developed for the
survey respondent to answer the items based upon their
own interpretation of “race” and how they use it in clinical
practice. The scale is a useful tool for assessing health care
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professionals’ education.
More broadly, the appropriate use of race in clinical
decision making remains contested [8] and the RACE
scale aims to provide empirical data to address this de-
bate. On one hand, use of race may heighten physicians’
recognition of social and cultural experiences of the pa-
tient and assist with clinical diagnoses based upon varying
prevalence of diseases and conditions. On the other, using
race may preclude personalized medicine and have life-
threatening implications for failure to diagnose a disease.
The value of the RACE scale is that it has the potential to
measure the use of race in clinical decision making.
Limitations
This study has four important limitations that merit
discussion and further research. These limitations are
related to the sample, survey response rate, the socio-
political context in which race, genetics and health are
embedded, and the exploratory nature of the study. The
sample was limited to primary care physicians in the USA.
General internists were selected because they are on the
frontlines of health care delivery and many treat adult pa-
tients with diverse backgrounds, health concerns and risk
profiles. Nonetheless, the sample is not representative of
all physicians. Differences in specialty, discipline, types
of responsibilities, even practice volume might affect
attitudes and beliefs. Nor does the sample include other
health care professionals (e.g., nurses) who are also on the
frontlines of healthcare services to diverse populations. For
these reasons, the findings from this study cannot be gen-
eralized. Researchers who wish to use the new measures
to study health professionals globally will need to establish
reliability and validity for those study populations.
A number of strategies were used to maximize survey
returns [45]; nonetheless the response rate was 45%, a
rate not uncommon in physician surveys. Although
limitations related to nonresponse are recognized in
this study, the similarity of the demographics between
the sample and the AMA database of physicians (see
Table 4) provides some evidence that our sample is
representative.
In the USA, discourse about race in general and race
and genetics in particular can be controversial [38]. Re-
spondents may have been uncomfortable with some of
the survey items resulting in non-response or socially
desirable responses. We excluded only 26 cases with in-
complete responses on the scale items and, as far as we
could determine, these appeared to be responses missing
at random. Further, we aimed to minimize the likelihood
of socially desirable response bias through use of web,
careful consideration of question order and wording,
and use of expert panels, focus groups, and cognitive
interviews.Our findings require additional research and confirm-
ation. While researchers can employ the RACE scale
with confidence about its reliability, the HPBR scale had
low convergent validity. Additional validity studies are
also needed for the GKAI. Further study might examine
whether physicians with more knowledge of human genetic
variation hold more nuanced understanding of the role of
race and ethnicity in health, and whether that understand-
ing is associated with clinical decision making.
Conclusions
Our measures make explicit the sometimes unarticulated
assumptions about relationships between race, genetics,
and health. Specifically we suggest that there is a complex
association between knowledge of human genetic vari-
ation, beliefs about race and genetics, and use of race in
clinical decision making processes. Developing mea-
sures that assess these three dimensions are needed if
medical educators and health professionals are to move
forward in efforts to understand, teach, practice, and
evaluate the associations between genomics and race.
These scales provide a tool to explore how physicians
think about the role of race and genomics in clinical care
and the use of race in treatment decisions. The scales
can be used to evaluate and assess knowledge and beliefs
in medical and health professional education and continu-
ing training. As we explore implicit attitudes of race with
physicians and medical students [22,23] we must also
examine explicit use of race in clinical care and health care
providers’ explicit attitudes and beliefs about the import-
ance of race in a clinical setting.
Medical advances and social and demographic changes
put pressure on the skills and knowledge of the primary
care physician and other health care professionals and can
challenge their ability to provide comprehensive care for
patients of different social, cultural, and ancestral back-
grounds. With genomic and personalized medicine we may
someday move beyond race and ethnicity as a surrogate for
genetic variation in health care. To move beyond race, will
require health care providers to have the skills to commu-
nicate to their patients the complex concepts of population
groups and human genetic variation [46]. Currently how-
ever, race and ethnicity serve as proxies for factors we are
only beginning to understand about the relationships be-
tween genetic variation and health, thus in this interim, we
need to deepen our understanding of health care providers
understanding of race and genetic variation and use of race
in their decision making. We anticipate that our measures
will contribute to ongoing debates about race, racial health
disparities, and genetics. The measures introduced here
provide researchers an opportunity to explore explicit use
of race in clinical decision making and could provide new
insights into health professionals’ knowledge and beliefs
about race, genetics, and health.
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aThe official titles of the scales are Bonham and Sellers
Genetic Variation Knowledge Assessment Index (GKAI),
Bonham and Sellers Health Professionals Beliefs about
Race (HPBR) scale, and the Bonham and Sellers Racial
Attributes in Clinical Evaluation (RACE) scale.
bThe conceptual model and scale development focused
on the concept ‘race’ and not ‘ethnicity’ because beliefs
about and use of ‘race’ have an important and complex
history within science and medicine in the USA.
cThe patient has an important role in clinical decisions.
The focus of the current paper is on the role of the pro-
vider. Future work will consider patient domains.
dFuture research will use the remaining sections to valid-
ate the scales.
eTwenty-six cases with incomplete responses on the
scale items were excluded from analysis.
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